DSM-Firmenich stock gains new resin capacity in France

dsm-firmenich announced on Monday, November 9, 2026, that production is ramping up at a new hydrogenated bio-based resins unit in Vielle-Saint-Girons in southwestern France. The company said the facility was commissioned during the first half of 2026 and manufactures DRT Industry Ingredients for industrial applications.

The announcement adds a new operational development to the company's current investor narrative after its third-quarter update raised the 2026 like-for-like sales growth outlook. The French unit expands production capacity in a business serving adhesives, coatings, paints and chewing gum, including applications in electronics, automotive products and road signage.

Capacity targets industrial demand

Amaury Roquette, Executive Vice President Ingredients, Perfumery & Beauty, said the investment strengthens dsm-firmenich's capabilities in high-end rosin resins. The company said the products are made from pine-based rosin and are intended to help customers reduce carbon emissions while meeting demand for naturally derived ingredients.

The plant will produce the hydrogenated rosin resins DRT Foral and Staybelite. According to dsm-firmenich, the process provides a high degree of hydrogenation, low color and stability under significant temperature changes and extreme climatic conditions. The company expects the additional unit to support customers globally, particularly in Europe, North America and Asia.

The site is fully automated and uses technologies aimed at safety, operational stability, quality and energy efficiency. More than 50 companies, 90% of them local, contributed to construction, alongside 120 equipment suppliers. The site is ISO 50001 certified and FSSC 22000 certified for chewing-gum resin production, while more than 90% of its co-products are valorized.

Stock trades without Xetra comparison

DSM-Firmenich stock traded at 108.55 euros on Lang & Schwarz at 10:17 CET on Monday, November 9, 2026; the real-time quote of DSM-Firmenich stock is available here.

Swiss equities were part of the broader market setting, with the SMI market environment providing the relevant regional reference.

For investors, the expansion gives the Ingredients, Perfumery & Beauty business additional industrial capacity and a platform for future product commercialization. More news and analyses on DSM-Firmenich stock are available in the company topic.